MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...
Nearly two years after Takeda pulled its US marketing application for a vaccine against dengue fever, MSD has advanced a rival shot into phase 3. The international MOBILIZE-1 trial is looking at a ...
Windows Update has improved dramatically over the past few years and is getting better. The Windows Team is now making it easier for consumers and businesses to locate the driver and optional updates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback